As of May 31
| +0.61 / +8.21%|
The 5 analysts offering 12-month price forecasts for Novavax Inc have a median target of 15.00, with a high estimate of 41.00 and a low estimate of 9.00. The median estimate represents a +86.57% increase from the last price of 8.04.
The current consensus among 6 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.